Please login to the form below
Zeria
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Zeria's Japan sales performance.
Omicron prompts global action
In fact, Japan has taken even stronger action, banning all foreigners from entering the country from 30 November.
AstraZeneca officially opens new R&D facility in UK
It will also play an important role in AZ’s R&D network, which already includes strategic research centres in Sweden and the US and development facilities in China and Japan.
CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
as we do in the US and Japan,” he added.
AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance
The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement.
AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China
Japan’s medicines regulator.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
B2B media account director
-
Competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- AstraZeneca blocks take-private buyout of Sobi
- Lilly’s combination antibody expanded to children under 12
- Working with purpose and putting talent development at the heart of operations
- A Lucid Thirsty Thursday D&I Special
- Diversity in clinical trials: looking back at our 2021 blogs
- MHRA approves second COVID-19 antibody treatment
- First trial of a vaccine against Alzheimer’s launches
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS
- Pfizer's 2021 revenue predictions soar to $82bn
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- Diversity in clinical trials: looking back at our 2021 blogs
- In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
